Mårten Fernö
111 – 120 of 258
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2010
-
Mark
Does Analysis of Biomarkers in Tumor Cells in Lymph Node Metastases Give Additional Prognostic Information in Primary Breast Cancer?
Falck, Anna-Karin LU ; Fernö, Mårten LU ; Bendahl, Pär-Ola LU and Rydén, Lisa LU
(2010)
In World Journal of Surgery
Apr 7.
p.1434-1441
- Contribution to journal › Article
-
Mark
The prognostic value of Ki67 is dependent on estrogen receptor status and histological grade in premenopausal patients with node-negative breast cancer.
(2010) In Modern Pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 23. p.251-259
- Contribution to journal › Article
-
Mark
Epidermal growth factor receptor and vascular endothelial growth factor receptor 2 are specific biomarkers in triple-negative breast cancer. Results from a controlled randomized trial with long-term follow-up.
Rydén, Lisa LU
; Jirström, Karin
LU
; Haglund, Monica
; Stål, Olle
and Fernö, Mårten
LU
(2010)
In Breast Cancer Research and Treatment
120.
p.491-498
- Contribution to journal › Article
-
Mark
Association between tumor tissue TIMP-1 levels and objective response to first-line chemotherapy in metastatic breast cancer.
- Contribution to journal › Article
-
Mark
Nuclear Janus-Activated Kinase 2/Nuclear Factor 1-C2 Suppresses Tumorigenesis and Epithelial-to-Mesenchymal Transition by Repressing Forkhead Box F1.
- Contribution to journal › Article
-
Mark
Cyclin B1 is a prognostic proliferation marker with a high reproducibility in a population-based lymph node negative breast cancer cohort.
Niméus, Emma LU ; Koliadi, A ; Ahlin, C ; Holmqvist, M ; Holmberg, Lars ; Amini, R-M ; Jirström, Karin LU
; Wärnberg, F
; Blomqvist, C
and Fernö, Mårten
LU
, et al.
(2010)
In International Journal of Cancer
127.
p.961-967
- Contribution to journal › Article
-
Mark
Modeling Prognostic Markers in Breast Cancer — Are We Using Them the Optimal Way?
Strand, C ; Falck, A-K ; Jirström, K LU
; Malmström, P
LU
; Rydén, L
LU
; Bendahl, P-O
LU
and Fernö, M.
LU
(2010)
In Cancer Research
70(24 Supplement).
- Contribution to journal › Published meeting abstract
-
Mark
Prediction of outcome after diagnosis of metachronous contralateral breast cancer
Alkner, Sara LU ; Bendahl, Pär-Ola LU ; Fernö, Mårten LU ; Manjer, Jonas LU and Ryden, Lisa LU
(2010)
San Antonio Breast Cancer Symposium 2010
In Cancer Research
70(Issue 24 suppl).
- Contribution to journal › Published meeting abstract
- 2009
-
Mark
Vascular endothelial growth factor receptor 2 is a significant negative prognostic biomarker in triple-negative breast cancer: results from a controlled randomised trial of premenopausal breast cancer
Rydén, Lisa LU
; Fernö, Mårten
LU
; Stal, O
; Linderholm, B.
; Ostman, A
and Jirström, Karin
LU
(2009)
31st Annual San Antonio Breast Cancer Symposium
In Cancer Research
69(2).
p.132-132
- Contribution to journal › Published meeting abstract
-
Mark
Significantly higher expression of vascular endothelial growth factor (VEGF) and shorter survival after recurrences in premenopausal node negative patients with triple negative breast cancer
- Contribution to journal › Published meeting abstract